New number of shares and votes in Isofol
GOTHENBURG, Sweden, April 30, 2026 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces new number of shares and votes […]
IR
Notice to attend the Annual General Meeting held on May 19, 2026 in Isofol Medical AB (publ)
GÖTEBORG, 15 april 2026 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) hereby invites the shareholders of Isofol Medical AB
Isofol optimizes the design of its phase Ib/II study following new regulatory approval
GOTHENBURG, Sweden, April 15, 2026 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) today announces that the German regulatory authority
Isofol Medical AB (publ) publishes annual report and corporate governance report for 2025
GOTHENBURG, Sweden, April 10, 2026 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), today announced that the company’s annual report
Isofol receives gross proceeds of 18.9 MSEK in connection with the exercise of warrants and guarantee commitments for warrants of series TO1, and resolves on a directed share issue
GOTHENBURG, Sweden, 31 March 2026 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) today announces that the exercise period for
Isofol secures license rights for arfolitixorin in autism
GOTHENBURG, Sweden, March 18, 2026 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) today announces that the company has expanded
The subscription price for warrants of series TO1 in Isofol has been set at SEK 0.48 and the exercise period commences on 16 March 2026
GOTHENBURG, Sweden, 13 March 2026 – Isofol Medical AB (“Isofol” or the “Company”) carried out a rights issue of units
Isofol receives top guarantee commitment and letters of intent corresponding to 42 percent of upcoming warrant exercise
GOTHENBURG, Sweden, 11 March 2026 – Isofol Medical AB (“Isofol” or the “Company”) announces today that the Company has received
Isofol’s Nomination Committee proposes election of Christian Haglund as new Board Director
GOTHENBURG, Sweden, March 9, 2026 – The Nomination Committee of Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) proposes re-election of
Isofol presents at investor meetings in March
GOTHENBURG, Sweden, March 3, 2026 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) announces today that the company will participate